-
Four Pitfalls to Avoid When Packaging Injectable Drug Products
contractpharma
September 05, 2019
When bringing a new injectable drug product to market, the packaging is quite important, especially considering the potential problems that can result with stability ...
-
Insilico Medicine develops new AI drug discovery system
pharmaceutical-technology
September 04, 2019
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic molecules.
-
China’s drug bulk-buy programme has been expanded
europeanpharmaceuticalreview
September 04, 2019
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
-
SpringWorks receives breakthrough status for desmoid tumour drug
pharmaceutical-technology
September 03, 2019
SpringWorks Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for nirogacestat...
-
Researchers find new drug with promise for malaria treatment
pharmaceutical-technology
September 03, 2019
An international research team led by the University of Glasgow has discovered a new drug that could kill the malaria-causing parasite, offering hope for the treatment of the disease.
-
Fasenra Granted Orphan Drug Designation
americanpharmaceuticalreview
September 03, 2019
AstraZeneca announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE).
-
Multiple myeloma treatment receives Orphan Drug Designation
europeanpharmaceuticalreview
September 03, 2019
Orphan drug designation has been granted to the CT053 anti-BCMA CAR-T program for multiple myeloma treatment.
-
Unique hydrogel strategy aids the delivery of drugs
europeanpharmaceuticalreview
September 02, 2019
Scientists have developed a hydrogel-based carrier that can deliver siRNAs directly to where they are needed.
-
Antibody Drug Conjugates Market to Be Worth $15bn by 2030
europeanpharmaceuticalreview
September 02, 2019
Antibody drug conjugates are presently recognised as a potent class of targeted anticancer therapies which will result in growth in the market.
-
Small molecules dominate FDA drug approvals this month
europeanpharmaceuticalreview
September 02, 2019
This August saw nine new green lights from the FDA, all small molecules, which makes up a third of the approvals this year.